McNicoll Lewis & Vlak Downgrades Clinical Data (CLDA) to Hold; Acquired by Forest (FRX) at $30 per Share Plus Contingent Payments
Tweet Send to a Friend
McNicoll Lewis & Vlak downgraded Clinical Data (NASDAQ: CLDA) from Buy to Hold.
McNicoll analyst says, "In our view, Forest ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
McNicoll analyst says, "In our view, Forest ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
